In the News


4 techniques most effective for getting patients active, analysis finds

Certain behavior change techniques implemented by clinicians were associated with increased physical activity by patients with type 2 diabetes, a recent analysis of a systematic review found.

Metformin appears more durable as monotherapy versus sulfonylurea or meglitinide, study finds

Metformin appeared to be effective as monotherapy for a longer period than sulfonylurea or meglitinide in treatment-naïve patients with type 2 diabetes, a recent study reports.

MKSAP quiz: Obese patient with elevated fasting glucose

This month's quiz asks readers to evaluate a 48-year-old woman who is concerned about her gradual weight gain over the years and requests counseling on how she can most effectively lose weight.

Commentary on the 2015 Standards for Diabetes Care

Of the many recommendations in the American Diabetes Association's (ADA) updated Standards of Medical Care in Diabetes, 3 were chosen as particularly important for nonendocrinologists by the authors of a recent commentary in Annals of Internal Medicine.

Review: In diabetes with multivessel or left main CAD, PCI increases death/MI/stroke combo compared with CABG

In patients with diabetes and multivessel disease or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) was associated with a higher rate of death, myocardial infarction (MI), or stroke than coronary artery bypass grafting (CABG), a meta-analysis found.

ICUs were faster to adopt tight glycemic control than to deadopt it

Glycemic control gradually tightened in U.S. ICUs after the publication of a trial supporting tight control, but practice changed little when a subsequent trial found harm from tight control, a new study notes.

Aflibercept approved for diabetic retinopathy in diabetic macular edema

Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced.

Spotlight on heart failure

The risk of heart failure in patients taking medication for type 2 diabetes was analyzed by 2 recent studies.